Sutro Biopharma (STRO) Revenue (QoQ) (2017 - 2025)
Sutro Biopharma (STRO) Revenue (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.91% |
| Sep 30, 2025 | -84.79% |
| Jun 30, 2025 | 266.37% |
| Mar 31, 2025 | 17.49% |
| Dec 31, 2024 | 73.81% |
| Sep 30, 2024 | -66.86% |
| Jun 30, 2024 | 97.62% |
| Mar 31, 2024 | -88.56% |
| Dec 31, 2023 | 571.95% |
| Sep 30, 2023 | 62.54% |
| Jun 30, 2023 | -17.85% |
| Mar 31, 2023 | 46.83% |
| Dec 31, 2022 | -65.67% |
| Sep 30, 2022 | -10.50% |
| Jun 30, 2022 | 376.45% |
| Mar 31, 2022 | -44.65% |
| Dec 31, 2021 | 25.09% |
| Sep 30, 2021 | -69.64% |
| Jun 30, 2021 | 91.33% |
| Mar 31, 2021 | 77.10% |